A PHASE II TRIAL WITH BEVACIZUMAB AND IRINOTECAN FOR PATIENTS WITH PRIMARY BRAIN TUMORS AND PROGRESSION AFTER STANDARD THERAPY

被引：0
|
作者：
Moller, Soren [1 ]
Grunnet, Kirsten [1 ]
Hansen, Steinbjorn [2 ]
Schultz, Henrik [3 ]
Holmberg, Mats [4 ]
Sorensen, Morten M. [1 ]
Poulsen, Hans S. [1 ]
Lassen, Ulrik [1 ]
机构：
[1] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark
[2] Odense Univ Hosp, Odense, Denmark
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] Aalborg Univ Hosp, Aalborg, Denmark
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [21] Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
    David A. Reardon
    Annick Desjardins
    Katherine Peters
    Sridharan Gururangan
    John Sampson
    Jeremy N. Rich
    Roger McLendon
    James E. Herndon
    Jennifer Marcello
    Stevie Threatt
    Allan H. Friedman
    James J. Vredenburgh
    Henry S. Friedman
    Journal of Neuro-Oncology, 2011, 103 : 371 - 379
  • [22] A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors
    Gan, Hui K.
    Rosenthal, Mark A.
    Dowling, Anthony
    Kalnins, Renate
    Algar, Elizabeth
    Wong, Nicholas
    Benson, Angela
    Woods, Anne-Marie
    Cher, Lawrence
    NEURO-ONCOLOGY, 2010, 12 (05) : 500 - 507
  • [23] Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma
    Peters, Katherine B.
    Lou, Emil
    Desjardins, Annick
    Reardon, David A.
    Lipp, Eric S.
    Miller, Elizabeth
    Herndon, James E., II
    McSherry, Frances
    Friedman, Henry S.
    Vredenburgh, James J.
    ONCOLOGIST, 2015, 20 (07): : 727 - 728
  • [24] PHASE II TRIAL OF BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION
    Ghiaseddin, Ashley
    Dunn-Pirio, Anastasie
    Peters, Katherine
    Vlahovic, Gordana
    Herndon, James, II
    Threatt, Stevie
    Sampson, John
    Friedman, Allan
    Friedman, Henry
    Desjardins, Annick
    NEURO-ONCOLOGY, 2014, 16
  • [25] Phase II trial of merbarone in patients with malignant brain tumors
    Ummekalsoom R. Malik
    Janice P. Dutcher
    Geralyn Caliendo
    Patrick Lasala
    Robin Mitnick
    Peter H. Wiernik
    Medical Oncology, 1997, 14 : 159 - 162
  • [26] Phase II trial of merbarone in patients with malignant brain tumors
    Malik, UR
    Dutcher, JP
    Caliendo, G
    Lasala, P
    Mitnick, R
    Wiernik, PH
    MEDICAL ONCOLOGY, 1997, 14 (3-4) : 159 - 162
  • [27] PHASE II TRIAL OF DOCETAXEL, CISPLATIN, IRINOTECAN, AND BEVACIZUMAB IN METASTATIC ESOPHAGOGASTRIC CANCER
    Enzinger, P.
    Fidias, P.
    Regan, E.
    Lehman, N.
    Abrams, T.
    Hezel, A.
    Sequist, L.
    Fuchs, C.
    Ryan, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 171 - 172
  • [28] Phase II trial of docetaxel, cisplatin, irinotecan, and bevacizumab in metastatic esophagogastric cancer
    Enzinger, P. C.
    Ryan, D. P.
    Regan, E. M.
    Lehman, N.
    Abrams, T. A.
    Hezel, A. F.
    Fidias, P.
    Sequist, L. V.
    Blaszkowsky, L. S.
    Fuchs, C. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] A phase II trial on the combination of bevacizumab and irinotecan in recurrent ovarian cancer.
    Ling, Huichung Tina
    Muggia, Franco
    Speyer, James L.
    Curtin, John Patrick
    Blank, Stephanie V.
    Boyd, Leslie R.
    Pothuri, Bhavana
    Li, Xiaochun
    Goldberg, Judith D.
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors
    Hedde, Jan-Peter
    Neuhaus, Thomas
    Schueller, Heinrich
    Metzler, Ute
    Schmidt-Wolf, Ingo G. H.
    Kleinschmidt, Rolf
    Losem, Christoph
    Lange, Oliver
    Grohe, Christian
    Stier, Sebastian
    Ko, Yon-Dschun
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 839 - 844
12345